Literature DB >> 15459812

HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.

Tomohiro Kato1, Hiroshi Asahara, Manae Suzuki Kurokawa, Koushi Fujisawa, Tomoko Hasunuma, Hajime Inoue, Masanao Tsuda, Shigeru Takahashi, Satoru Motokawa, Takayuki Sumida, Kusuki Nishioka.   

Abstract

Our objective was to investigate the pathological mechanisms of HTLV-I (human T-cell leukemia virus type I)-associated chronic arthritis (HAAP) with respect to T-cell response to HTLV-I viral proteins. We examined T-cell clonality and the antigen recognized by T cells from the inflamed synovium of patients with HAAP by using histology, a single-strand conformation polymorphism (SSCP) analysis and T cell receptor (TCR) sequencing. The SSCP analysis showed oligoclonal expansion of T cells in the synovium, suggesting an antigen-mediated stimulation. In contrast, there was less clonal expansion in peripheral blood lymphocytes (PBL). The expression of HTLV-1 env and tax mRNA was detected in the affected synovium as well as in PBL. A number of T-cell clones in the synovium recognized HTLV-I env and tax proteins. Twenty-seven (24.9%) of 109 examined T-cell clones in the joints were HTLV-I env reactive, and 7 clones (6.4%) were HTLV-I tax reactive. Junctional sequence analysis of synovial T cells showed a lack of highly conserved amino acid motifs in the complementarity-determining region 3 (CDR3) of HTLV-I env and tax reactive T cells, suggesting that these cells recognized multiple T-cell epitopes on HTLV-I antigen. These findings suggest that HTLV-I env protein acts as a major antigen and may play a role in the development of arthropathy in patients with HAAP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459812     DOI: 10.1007/s10067-004-0901-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.

Authors:  T A Höger; S Jacobson; T Kawanishi; T Kato; K Nishioka; K Yamamoto
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

2.  In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium.

Authors:  H Asahara; T Hasunuma; T Kobata; H Inoue; U Muller-Ladner; S Gay; T Sumida; K Nishioka
Journal:  J Rheumatol       Date:  1997-03       Impact factor: 4.666

3.  Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.

Authors:  J E Green; S H Hinrichs; J Vogel; G Jay
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

4.  Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features.

Authors:  K Sato; I Maruyama; Y Maruyama; I Kitajima; Y Nakajima; M Higaki; K Yamamoto; N Miyasaka; M Osame; K Nishioka
Journal:  Arthritis Rheum       Date:  1991-06

5.  Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis.

Authors:  A Sottini; L Imberti; R Gorla; R Cattaneo; D Primi
Journal:  Eur J Immunol       Date:  1991-02       Impact factor: 5.532

6.  Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.

Authors:  S Jacobson; J S Reuben; R D Streilein; T J Palker
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

7.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

8.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.

Authors:  K Terada; S Katamine; K Eguchi; R Moriuchi; M Kita; H Shimada; I Yamashita; K Iwata; Y Tsuji; S Nagataki
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

10.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  3 in total

1.  Human T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo.

Authors:  Ihab Younis; Brenda Yamamoto; Andrew Phipps; Patrick L Green
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.

Authors:  Won-Kyung Cho; Meisheng Zhou; Moon Kyoo Jang; Keven Huang; Soo-Jin Jeong; Keiko Ozato; John N Brady
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

3.  IFNG +874A/T Polymorphism Among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis.

Authors:  Maria A F Queiroz; Vânia N Azevedo; Ednelza da S G Amoras; Tuane C F Moura; Marluísa de O Guimarães Ishak; Ricardo Ishak; Antonio C R Vallinoto; Rosimar N Martins Feitosa
Journal:  Front Microbiol       Date:  2018-05-18       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.